Sun Pharma
REPORT ON SUN PHARMACEUTICAL
CONTENTS
1. INTRODUCTION
2. GROUP OF COMPANIES
3. FORMULATION OF MANUFACTURING
4. UNIQUE PROFILE OF SUN PHARMACEUTICAL
5. SWOT ANALYSIS
6. PESTLE ANALYSIS
7. PORTER’S FIVE FORCE ANALYSIS
8. FINDINGS & CONCLUSION
9. RECCOMMENDATIONS
INTRODUCTION TO THE ORGANISATION
Sun Pharmaceuticals was set up in 1983 and the company started off with only 5 products to cure psychiatric illness. Sun Pharma is best known worldwide as the manufacture of specialty Active Pharmaceuticals Ingredients and formulations.
However, the company is also concerned with chronic treatments such as cardiology, psychiatry, neurology, gastroenterology, diabetology, and respiratory ailments. Active Pharmaceuticals Ingredients (API) includes peptides, steroids, hormones, and anti-cancer drugs and their quality is internationally approved. The international offices of Sun Pharmaceuticals Industries Ltd. are located in British Virgin Islands, Russia, and Bangladesh. In India, the offices are in Vapi, Silvassa, Panoli, Ahmednagar, and Chennai. Dilip S. Shanghvi is the Executive Chairman and Managing Director of Sun Pharma and Kamalesh H. Shah is the Secretary.
There are 3 major group companies of Sun Pharmaceuticals Industries are:
• Caraco Pharmaceuticals Laboratories (based in Detroit, Michigan)
• Sun Pharmaceuticals Industries Inc. (Michigan)
• Sun Pharmaceuticals (Bangladesh)
In 1983, when Sun Pharma was set up, it only dealt with two cities in India – West Bengal and Bihar. In 1985, it started trading nationally and by 2000, Sun Pharmaceuticals made its way through the international market. Products used in cardiology were manufactured in 1987 and at that time, Monotrate was one of the first products that was launched and went on to become a best-seller. In 1993, Sun Pharmaceuticals Industries set up their own research institute and named it SPARC. SPARC became popular by generating knowledge and honing process development skills across the
CONTENTS
1. INTRODUCTION
2. GROUP OF COMPANIES
3. FORMULATION OF MANUFACTURING
4. UNIQUE PROFILE OF SUN PHARMACEUTICAL
5. SWOT ANALYSIS
6. PESTLE ANALYSIS
7. PORTER’S FIVE FORCE ANALYSIS
8. FINDINGS & CONCLUSION
9. RECCOMMENDATIONS
INTRODUCTION TO THE ORGANISATION
Sun Pharmaceuticals was set up in 1983 and the company started off with only 5 products to cure psychiatric illness. Sun Pharma is best known worldwide as the manufacture of specialty Active Pharmaceuticals Ingredients and formulations.
However, the company is also concerned with chronic treatments such as cardiology, psychiatry, neurology, gastroenterology, diabetology, and respiratory ailments. Active Pharmaceuticals Ingredients (API) includes peptides, steroids, hormones, and anti-cancer drugs and their quality is internationally approved. The international offices of Sun Pharmaceuticals Industries Ltd. are located in British Virgin Islands, Russia, and Bangladesh. In India, the offices are in Vapi, Silvassa, Panoli, Ahmednagar, and Chennai. Dilip S. Shanghvi is the Executive Chairman and Managing Director of Sun Pharma and Kamalesh H. Shah is the Secretary.
There are 3 major group companies of Sun Pharmaceuticals Industries are:
• Caraco Pharmaceuticals Laboratories (based in Detroit, Michigan)
• Sun Pharmaceuticals Industries Inc. (Michigan)
• Sun Pharmaceuticals (Bangladesh)
In 1983, when Sun Pharma was set up, it only dealt with two cities in India – West Bengal and Bihar. In 1985, it started trading nationally and by 2000, Sun Pharmaceuticals made its way through the international market. Products used in cardiology were manufactured in 1987 and at that time, Monotrate was one of the first products that was launched and went on to become a best-seller. In 1993, Sun Pharmaceuticals Industries set up their own research institute and named it SPARC. SPARC became popular by generating knowledge and honing process development skills across the